Pharmacokinetics of colistin after nebulization or intravenous administration of colistin methanesulphonate (Colimycin ®) to cystic fibrosis patients
Colistin, administered as the prodrug colistin methanesulphonate (CMS), is an antibiotic frequently administered as aerosol in cystic fibrosis (CF) patient. Our aim was to assess the plasma PK of colistin in CF patients treated with CMS administered intravenously or as aerosol and to compare these results with those previously reported in healthy volunteers.
Source: Journal of Cystic Fibrosis - Category: Respiratory Medicine Authors: Sophie Magr éault, Julie Mankikian, Sandrine Marchand, Patrice Diot, William Couet, Thomas Flament, Nicolas Grégoire Tags: Original Article Source Type: research
More News: Cystic Fibrosis | Respiratory Medicine